All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Angiotensin Ii Antagonists Combined With Anti Hypertensives

Olkem Trio 6.25 Tablet

(Olmesartan Medoxomil (20mg) + Cilnidipine (10mg) + Chlorthalidone (6.25mg))

Uses, side effects, dosage information & price range

Alkem Laboratories Ltd121.97

About this medicine

Olkem Trio 6.25 Tablet is a combination of medicines used to treat hypertension (high blood pressure) when a single medication is not effective. It helps to lower high blood pressure thus reduces chances of future heart attack and stroke.Olkem Trio 6.25 Tablet should be taken with food. The dose wil

What are the side effects of Olmesartan Medoxomil (20mg) + Cilnidipine (10mg) + Chlorthalidone (6.25mg) (Olkem Trio 6.25 Tablet)?

Not everyone experiences these side effects. Consult your doctor if any persist.

  • Ankle swelling
  • Headache
  • Dizziness
  • Tiredness
  • Palpitations

Common Brand Names for this Composition

The following popular commercial brand names contain Olmesartan Medoxomil (20mg) + Cilnidipine (10mg) + Chlorthalidone (6.25mg) as their active ingredient composition:

Olkem Trio 6.25 Tablet

Alkem Laboratories Ltd

MRP₹121.97

Key Information

Salt / Composition

Olmesartan Medoxomil (20mg) + Cilnidipine (10mg) + Chlorthalidone (6.25mg)

Category

Angiotensin Ii Antagonists Combined With Anti Hypertensives

Manufacturer

Alkem Laboratories Ltd

Price (MRP)

121.97

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.